Specifications
Immunogen
A synthetic peptide corresponding to residues in Human TAF9b (UniProt ID: Q9HBM6).
Applications
Application Notes
WB: 1/1000 - 1/10000; IHC-P: 1/250 - 1/500.
Target
Alternative Names
TAF9B; TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa; TAF9 like RNA polymerase II, TATA box binding protein (TBP) associated factor, 31kDa , TAF9L; transcription initiation factor TFIID subunit 9B; DN 7; DN7; TAFII31L; T
Product Background
Antigen Description
Essential for cell viability. TAF9 and TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. May have a role in gene regulation associated with apoptosis. TAFs are components of the transcription factor IID (TFIID) complex, the TBP-free TAFII complex (TFTC), the PCAF histone acetylase complex and the STAGA transcription coactivator-HAT complex. TFIID or TFTC are essential for the regulation of RNA polymerase II-mediated transcription.
Pathway
Basal transcription factors, organism-specific biosystem; Basal transcription factors, conserved biosystem; Herpes simplex infection, organism-specific biosystem; Herpes simplex infection, conserved biosystem.
Citations
Publication ()
Have you cited DCABH-2615 in a publication?
Let us know and earn a reward for your research.
COA
Loading ......
